Harvard Catalyst Profiles

Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland	MBBCh	2014	Medicine
NewYork Presbytarian Hospital / Weill Cornell Medicine, New York, USA	Resident	2017	Internal Medicine
NewYork Presbytarian Hospital / Weill Cornell Medicine , New York, USA	Chief Resident	2018	Internal Medicine
Brigham and Women's Hospital / Harvard Medical School, Boston, USA	Fellow	2021	Cardiovascular Medicine
Brigham and Women's Hospital / Harvard Medical School , Boston, MA	Chief Fellow	2021	Cardiovascular Medicine
Smith Center for Outcomes Research at BIDMC, Boston, USA	Fellow	2021	Outcomes Research
Harvard University, Boston, USA	Master's in Public Health	2021	Clinical Effectivness

Zaid Almarzooq, MBBCh, MPH is a board-certified cardiologist who completed his medical school at the Royal College of Surgeons in Ireland in 2014, internal medicine residency at NewYork Presbyterian Hospital/Weill Cornell Medicine (New York, NY) in 2017, and cardiology fellowship at Brigham and Women's Hospital/Harvard Medical School in 2018. He also completed a Master's in Public Health at Harvard University in 2021 and Post-doctoral Research Fellowship at the Smith Center for Outcomes Research at Harvard University in 2021. He has held numerous leadership positions including Chief Medical Resident in 2018 and Chief Cardiovascular Medicine Fellow in 2019. He also served on the Board of Directors of the National Residency Matching Program. He has been inducted into the Alpha Omega Honor Medical Society and the Gold Humanism Honor Society. He is also a recipient of numerous awards, most recently the Richard Gorlin Award for Excellence Cardiovascular Medicine Research.

His clinical expertise is in cardiovascular medicine with a special focus on novel techniques in percutaneous coronary interventions and structural heart disease interventions. He is a Fellow of the American College of Cardiology and Fellow of the Society of Cardiovascular Angiography and Interventions.

His research focuses on the application of causal inference methods to cardiovascular care and disease. He has received several research grants and awards and serves on several national committees including the AHA Epidemiology and Statistics Committee, AHA/ACC Task Force on Performance Indicators, and the ACC TVT Research and Publications Committee. He has also served on the editorial board of the American College of Cardiology ACCEL.